Filing Details

Accession Number:
0000899243-20-035011
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-23 17:35:45
Reporting Period:
2020-12-21
Accepted Time:
2020-12-23 17:35:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214133 H Richard Scheller C/O Bridgebio Pharma, Inc.
421 Kipling Street
Palo Alto CA 94301
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-21 14,928 $64.81 91,333 No 4 S Direct
Common Stock Disposition 2020-12-21 45,473 $65.48 45,860 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average sale price of the shares sold from $64.15 to $65.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2.
  2. Represents the weighted average sale price of the shares sold from $65.15 to $65.76 per share.